期刊文献+
共找到8篇文章
< 1 >
每页显示 20 50 100
移植静脉病防治的研究进展 被引量:3
1
作者 程永庆 邹榕江 王东进 《心脏杂志》 CAS 2012年第6期777-779,共3页
自体静脉作为桥血管材料移植到动脉环境后发生的移植静脉病,目前仍是心血管外科尚未解决的难题。现就近年来在移植静脉病的防治方面的研究现状进行综述。
关键词 移植静脉病 预防 治疗
下载PDF
移植静脉病基因治疗基础研究和临床应用
2
作者 张小宁 庄建 《中国心血管病研究》 CAS 2017年第2期113-117,共5页
自体静脉是动脉重建术的常用材料。然而,自体静脉移植术后,由于自体静脉经受缺血、损伤、炎症反应和承受动脉血的高压等因素,早期可能出现移植静脉痉挛、栓塞,随后可产生移植静脉内膜增生和粥样硬化,偶见血管瘤,这些现象统称为移... 自体静脉是动脉重建术的常用材料。然而,自体静脉移植术后,由于自体静脉经受缺血、损伤、炎症反应和承受动脉血的高压等因素,早期可能出现移植静脉痉挛、栓塞,随后可产生移植静脉内膜增生和粥样硬化,偶见血管瘤,这些现象统称为移植静脉病(vein graft disease),其严重影响着冠脉搭桥术(coronary artery bypass grafting,CABG)和外周血管疾病术后的临床效果。因移植静脉在离体后可先进行基因转染,然后移植,所以从理论上讲移植静脉是理想的基因治疗靶标,移植静脉病基因治疗成为心血管外科研究的前沿。本文就移植静脉病基因治疗相关基础研究与临床应用进行总结。 展开更多
关键词 移植静脉病 基因治疗
下载PDF
降钙素基因相关肽转基因对移植静脉病的防治作用
3
作者 张小宁 庄建 +4 位作者 吴红穗 陈志红 苏健 陈世良 陈剑光 《中国胸心血管外科临床杂志》 CAS CSCD 2017年第11期880-885,共6页
目的研究降钙素基因相关肽(calcitonin gene-related peptide,CGRP)转基因对移植静脉病的防治作用,并探索作用机制。方法将25只雄性新西兰白兔随机分为3组:实验组(n=8),取兔颈静脉,转染含CGRP基因的重组腺相关病毒2/1型载体(mosaic aden... 目的研究降钙素基因相关肽(calcitonin gene-related peptide,CGRP)转基因对移植静脉病的防治作用,并探索作用机制。方法将25只雄性新西兰白兔随机分为3组:实验组(n=8),取兔颈静脉,转染含CGRP基因的重组腺相关病毒2/1型载体(mosaic adeno-associated virus vector tipe 2/1 containing CGRP gene,AAV2/1-CGRP);载体组(n=9),转染含β-半乳糖苷酶基因z的重组腺相关病毒2/1型载体(mosaic adenoassociated virus vector tipe 2/1 containing LacZ gene,AAV2/1-LacZ)和对照组(n=8),采用生理盐水,反向端-侧吻合植入同侧颈动脉。于术后4周取标本行病理、CD68免疫组化、β-半乳糖苷酶原位染色。逆转录聚合酶链式反应(reverse transcription-polymerase chain reaction,RT-PCR)观察CGRP基因表达,实时荧光定量聚合酶链式反应(real-time polymerase chain reaction,real-time PCR)测定单核细胞趋化因子-1(monocyte chemoattractant protein-1,MCP-1)、肿瘤坏死因子α(tumour necrosis factor-α,TNF-α)、诱导型一氧化氮合酶(inducible nitric oxide synthase、iNOS)、基质金属蛋白酶-9(matrix metalloproteinase-9,MMP-9)。结果实验组CGRP基因表达阳性,载体组β-半乳糖苷酶原位染色阳性。实验组内膜面积/中膜面积比值显著低于对照组和载体组。实验组MCP-1、TNF-α、iNOS、MMP-9显著低于对照组和载体组。结论 CGRP基因表达抑制了巨噬细胞浸润及炎症因子MCP-1、TNF-α、iNOS、MMP-9的表达,通过多种机制保护移植静脉,发挥防治移植静脉病的作用。 展开更多
关键词 移植静脉病 降钙素基因相关肽 基因治疗
原文传递
Hepatic venous outflow obstruction after piggyback liver transplantation by an unusual mechanism:Report of a case 被引量:2
4
作者 Simon Siu-Man Ng Simon Chun-Ho Yu +2 位作者 Janet Fung-Yee Lee Paul Bo-San Lai Wan-Yee Lau 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第33期5416-5418,共3页
Hepatic venous outflow obstruction after piggyback liver transplantation is a very rare complication. An unusual mechanism aggravating it is reported. A 33-year-old man with end-stage hepatitis B liver cirrhosis under... Hepatic venous outflow obstruction after piggyback liver transplantation is a very rare complication. An unusual mechanism aggravating it is reported. A 33-year-old man with end-stage hepatitis B liver cirrhosis underwent a piggyback orthotopic liver transplantation using a full-size cadaveric graft. Two months after transplantation, he developed gross ascites refractory to maximal diuretic therapy. Doppler ultrasound showed patent portal and hepatic veins. Serial computed tomography scans revealed a hypoperfused right posterior segment of the liver which subsequently underwent atrophy. Hepatic venography demonstrated a high-grade stenosis with an element of torsion of venous drainage at the anastomosis. The stenosis was successfully treated with repeated percutaneous balloon angioplasty. The patient remained asymptomatic six months afterwards with complete resolution of ascites and peripheral edema. We postulate that liver allograft segmental hypoperfusion and atrophy may aggravate or result in a hepatic venous outflow problem by the mechanism of torsion effect. Percutaneous balloon angioplasty is a safe and effective treatment modality for anastomotic stenosis. 展开更多
关键词 Hepatic venous outflow obstruction PIGGYBACK Liver transplantation Percutaneous balloon angioplasty
下载PDF
Liver transplantation for polycystic liver with massive hepatomegaly: A case report 被引量:6
5
作者 Wei-Wei Jiang Feng Zhang +2 位作者 Li-Yong Pu Xue-Hao Wang Lian-Bao Kong 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第40期5112-5113,共2页
A previous study has shown that liver or combined liver-kidney transplantation can be a valuable surgical technique for the treatment of polycystic liver disease. Herein, we present the case of a 35-year-old woman wit... A previous study has shown that liver or combined liver-kidney transplantation can be a valuable surgical technique for the treatment of polycystic liver disease. Herein, we present the case of a 35-year-old woman with polycystic liver disease, who underwent orthotopic liver transplantation (OLT) on November 11, 2008. The whole-size graft was taken from a deceased donor (a 51-year-old man who died of a heart attack). Resection in a patient with massive hepatomegaly is very difficult. Thus, after intercepting the portal hepatic vein, left hepatectomy was performed, then the vena cava was intercepted, the second and third porta hepatic isolated, and fi nally, right hepatectomy was performed. OLT was performed successfully. The recipient did well after transplantation. This case suggested that OLT is an effective therapeutic option for polycystic liver disease and left hepatectomy can be performed fi rst during OLT if the liver is over enlarged. 展开更多
关键词 HEPATECTOMY Liver transplantation Polycystic liver
下载PDF
Combined pancreatoduodenectomy and orthotopic liver transplantation for hepatocellular carcinoma with portal vein tumor thrombus:A case report
6
作者 Chang Liu Qifei Wu Bo Wang Zheng Wu Xuemin Liu Xiaogang Zhang Liang Yu Yi Lv Cheng'en Pan 《The Chinese-German Journal of Clinical Oncology》 CAS 2009年第12期734-736,共3页
Hepatocellular cancer(HCC) is the most common primary malignant hepatic tumor that accounts for over 80% of primary liver tumors.The outlook for HCC is dismal if it is left untreated and the treatment for patients wit... Hepatocellular cancer(HCC) is the most common primary malignant hepatic tumor that accounts for over 80% of primary liver tumors.The outlook for HCC is dismal if it is left untreated and the treatment for patients with HCC evolved into a complex task.The treatments for HCC are mainly surgical therapies including hepatic resection(HR) and liver transplantation.Although HR is a well accepted therapy for HCC,it is not suitable for patients with advanced cirrhosis.Orthotopic liver transplantation(OLT) is considered more appropriate in cases with HCC related to cirrhosis,because it may eliminate both the tumor and the underlying liver disease.In this study,we reported a patient with HCC and portal vein tumor thrombus underwent combined pancreatoduodenectomy with OLT and survived 23 months in our center. 展开更多
关键词 hepatocellular carcinoma (HCC) liver transplantation portal vein tumor thrombus PANCREATODUODENECTOMY
下载PDF
Intravenous prograf in maintenance treatment of intestinal obstruction complicated with hepatic function injury after renal transplantation: a case report
7
作者 Zhang Xin Han Shu Fu Shangxi Zhou Meisheng Wang Liming 《Journal of Medical Colleges of PLA(China)》 CAS 2011年第5期301-304,共4页
For renal transplant recipients, intestinal obstruction caused by incisional hernia is a rarely encountered event. Until now, there is no specific literature concerning the adjustment of immunosuppressants under such ... For renal transplant recipients, intestinal obstruction caused by incisional hernia is a rarely encountered event. Until now, there is no specific literature concerning the adjustment of immunosuppressants under such clinical condition. We present such a case who received a successful long-term single intravenous prograf administration to transitionally maintain the immunosuppression. 展开更多
关键词 Renal transplantation Intestinal obstruction Intravenous prograf
下载PDF
Transjugular intrahepatic portosystemic shunt in liver transplant recipients 被引量:8
8
作者 Armin Finkenstedt Ivo W Graziadei +4 位作者 Karin Nachbaur Werner Jaschke Walter Mark Raimund Margreiter Wolfgang Vogel 《World Journal of Gastroenterology》 SCIE CAS CSCD 2009年第16期1999-2004,共6页
AIM: To evaluate the efficacy of transjugular intrahepatic portosystemic shunts (TIPSs) after liver transplantation (LT). METHODS: Between November 1996 and December 2005, 10 patients with severe recurrent hepat... AIM: To evaluate the efficacy of transjugular intrahepatic portosystemic shunts (TIPSs) after liver transplantation (LT). METHODS: Between November 1996 and December 2005, 10 patients with severe recurrent hepatitis C virus infection (n = 4), ductopenic rejection (n = 5) or portal vein thrombosis (n = 1) were included in this analysis. Eleven TIPSs (one patient underwent two TIPS procedures) were placed for management of therapy-refractory ascites (n = 7), hydrothorax (n = 2) or bleeding from colonic varices (n = 1). The median time interval between LT and TIPS placement was 15 (4-158) mo. RESULTS: TIPS placement was successful in all patients. The mean portosystemic pressure gradient was reduced from 12.5 to 8.7 mmHg. Complete and partial remission could be achieved in 43% and 29% of patients with ascites. Both patients with hydrothorax did not respond to TIPS. No recurrent bleeding was seen in the patient with colonic varices. Nine of 10 patients died during the study period. Only one of two patients, who underwent retransplantation after the TIPS procedure, survived. The median survival period after TIPS placement was 3.3 (range 0.4-20) too. The majority of patients died from sepsis with multiorgan failure. CONCLUSION: Indications for TIPS and technical performance in LT patients correspond to those in non-transplanted patients. At least partial control of therapy-refractory ascites and variceal bleeding could be achieved in most patients. Nevertheless, survival rates were disappointing, most probably because of the advanced stages of liver disease at the time of TIPS placement and the high risk of sepsis as a consequence of immunosuppression. 展开更多
关键词 Portal hypertension ASCITES Variceal bleeding IMMUNOSUPPRESSION Liver transplantation
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部